Churg-Strauss Syndrome

A Unique Combination of Vasculitis, Eosinophilia, and Asthma

© Elaine Moore

Churg-Strauss syndrome is an autoimmune triad that initially emerges as allergic rhinitis and later progresses to eosinophilia and vasculitis. Read on to learn more.

The unique condition of vasculitis known as Churg-Strauss syndrome (CSS) was first described in the early 1950’s. As a syndrome, Churg-Strauss is characterized by the presence of the following three conditions:

  1. Asthma
  2. Small vessel necrotizing (causing tissue damage and destruction) Vasculitis
  3. Eosinophilia, a condition of increased eosinophils, which are a type of white blood cell usually increased in severe allergic reactions

The recurring form of vasculitis that occurs in Churg-Strauss syndrome is accompanied by the presence of anti-neutrophil cytoplasmic antibodies (ANCA), especially perinuclear ANCA (P-ANCA) that react with myeloperoxidase. These P-ANCA or myeloperoxidase autoantibodies, are also seen in other conditions of vasculitis affecting small to medium vessels. Some patients with Churg-Strauss syndrome also develop extravascular (in locations other than blood vessels, for instance the lungs or kidneys) tissue granulomas, which contain clusters of white blood cells, including eosinophils.

Symptoms

Churg-Strauss syndrome initially causes a condition of allergic rhinitis, which may be complicated by nasal polyps and sinusitis. Symptoms of asthma are usually present and often accompanied by pulmonary infiltrates (deposits of white blood cells). Individual features characteristic of allergic rhinitis, asthma or vasculitis can also occur, making the disease course and symptom type and severity different among different individuals. In some cases ,coronary arteritis and gastrointestinal involvement occur.

Churg-Strauss syndrome primarily affects the small blood vessels of the upper and lower respiratory tract and occurs in patients with asthma and prominent tissue and blood eosinophilia. Systemic vasculitis is similar to that seen in polyarteritis nodosa although in Churg-Strauss syndrome the presence of severe renal (kidney) disease is rarely seen. Vasculitis in CSS is usually self-limited and of short duration although relapses can occur.

Disease Course

Churg-Strauss syndrome occurs in three phases:

Treatment:

Treatment for Churg-Strauss syndrome primarily consists of corticosteroids and immunosuppressant medications, which are used to reduce inflammation. Specific treatments, such as antihistamines, are used to reduce symptoms of allergic rhinitis.

Resources:

KA Keogh and U Specks, Churg-Strauss syndrome: update on clinical, laboratory, and therapeutic aspects, Sarcoidsosis Vasculitis Diffuse Lung Disorders 2006 Marl 2391): 3-12.

JG Lanham, K Elkon, C Pusey and G Hughes, Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

P Manganelli, R Troise, W Buzio, G Pavesi, and F. Gemignani, Churg-Strauss syndrome: Personal caseload and review of the literature, Minerva Medicine, July-August 1994: 387-393.


The copyright of the article Churg-Strauss Syndrome in Autoimmune Disease is owned by Elaine Moore. Permission to republish Churg-Strauss Syndrome must be granted by the author in writing.




Post this Article to facebook Add this Article to del.icio.us! Digg this Article furl this Article Add this Article to Reddit Add this Article to Technorati Add this Article to Newsvine Add this Article to Windows Live Add this Article to Yahoo Add this Article to StumbleUpon Add this Article to BlinkLists Add this Article to Spurl Add this Article to Google Add this Article to Ask Add this Article to Squidoo